Technical Analysis for PYC - Physiomics Plc
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 50 DMA Resistance | Bearish | 0.00% | |
| Crossed Above 20 DMA | Bullish | 0.00% | |
| MACD Bullish Signal Line Cross | Bullish | 0.00% | |
| Pocket Pivot | Bullish Swing Setup | 0.00% | |
| Outside Day | Range Expansion | 0.00% | |
| Upper Bollinger Band Touch | Strength | 0.00% | |
| NR7 | Range Contraction | 13.04% | |
| NR7-2 | Range Contraction | 13.04% | |
| Narrow Range Bar | Range Contraction | 13.04% | |
| NR7 | Range Contraction | 13.04% |
| Alert | Time |
|---|---|
| Possible Pocket Pivot | 1 day ago |
| Rose Above Upper Bollinger Band | 1 day ago |
| Rose Above 50 DMA | 1 day ago |
| Up 1 ATR | 1 day ago |
| Fell Below Previous Day's Low | 1 day ago |
Get a Trading Assistant
Physiomics Plc Description
Physiomics Plc is engaged in the provision of outsourced systems and computational biology services to pharmaceutical companies. The Company is focused on the development of Virtual Tumour Clinical, to directly predict optimal regimens for human clinical trials; Cardiac tox prediction service, to predict unwanted toxic side effects of drug candidates in the drug discovery process, and Drug combinations database, for researchers and clinicians to access literature data on pre-clinical and clinical regimens and their effects. Its services include Target Validation, Mechanism of Action Studies, Lead Selection, Clinical Pharmacokinetic/Pharmacodynamics (PK/PD), EASYAP/Cardiac Toxicity Service, Virtual Tumour Preclinical and Virtual Tumour Clinical. It offers a services and technology for predicting cardiac toxicity. It also focuses on offering offer Model Based Drug Development (MBDD) services, which include Population PKPD analysis of clinical data and Back-translational analysis.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Health Pharmaceutical Clinic Biology Pharmaceutical Industry Drug Discovery Clinical Trial Drug Development Health Sciences Omics Translation Validation Dynamics Pharmaceutical Companies Pre Clinical Development
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 3.288 |
| 52 Week Low | 0.9 |
| Average Volume | 438,799 |
| 200-Day Moving Average | 1.47 |
| 50-Day Moving Average | 1.33 |
| 20-Day Moving Average | 1.24 |
| 10-Day Moving Average | 1.18 |
| Average True Range | 0.15 |
| RSI (14) | 54.13 |
| ADX | 14.6 |
| +DI | 26.78 |
| -DI | 11.41 |
| Chandelier Exit (Long, 3 ATRs) | 1.05 |
| Chandelier Exit (Short, 3 ATRs) | 1.52 |
| Upper Bollinger Bands | 1.39 |
| Lower Bollinger Band | 1.08 |
| Percent B (%b) | 0.71 |
| BandWidth | 25.13 |
| MACD Line | -0.04 |
| MACD Signal Line | -0.05 |
| MACD Histogram | 0.01 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 1.75 | ||||
| Resistance 3 (R3) | 1.73 | 1.57 | 1.68 | ||
| Resistance 2 (R2) | 1.57 | 1.45 | 1.58 | 1.65 | |
| Resistance 1 (R1) | 1.43 | 1.38 | 1.50 | 1.45 | 1.62 |
| Pivot Point | 1.27 | 1.27 | 1.30 | 1.28 | 1.27 |
| Support 1 (S1) | 1.13 | 1.15 | 1.20 | 1.15 | 0.98 |
| Support 2 (S2) | 0.97 | 1.08 | 0.98 | 0.95 | |
| Support 3 (S3) | 0.83 | 0.97 | 0.93 | ||
| Support 4 (S4) | 0.85 |
